不孕症治療市場規模、佔有率和成長分析（按產品、手術、患者類型、最終用戶和地區分類）—2026-2033年產業預測

預計到 2024 年，不孕症治療市場規模將達到 40.6 億美元，到 2025 年將達到 43.4 億美元，到 2033 年將達到 74.1 億美元，在預測期（2026-2033 年）內，複合年成長率為 6.9%。

全球不孕症治療市場正經歷顯著成長，其主要促進因素包括不孕症上升、女性生育年齡成長、生活方式改變以及醫療技術的突破性進展。全球相當一部分人口面臨不孕症的困擾，這推動了對有效且創新治療方案的需求。輔助生殖技術（ART），例如體外受精（IVF）和卵胞漿內單一精子注射（ICSI），正逐漸成為主流選擇，並受益於不斷提高的成功率和患者療效的技術進步。隨著這些技術的普及和價格的降低，預計該市場將進一步擴張。此外，人們對第三方輔助生殖的接受度不斷提高、可支配收入的增加以及生育年齡的變化趨勢等因素，也共同推動了不孕症治療領域的發展。

生育治療市場促進因素

全球不孕症的上升趨勢可歸因於生活方式改變、生育年齡延遲以及環境因素等。隨著越來越多的個人和夫婦面臨生育挑戰，對各種不孕症治療方法的需求也日益成長。此外，醫療技術的進步，特別是體外受精（IVF）和卵胞漿內單一精子注射（ICSI）等輔助生殖技術的進步，顯著提高了治療成功率，使這些治療方法更加有效和普及。這些因素共同推動了不孕症治療市場的成長。

限制生育治療市場的因素

不孕症治療市場面臨的主要挑戰之一是體外受精（IVF）和基因檢測等先進療法的高昂費用。這種經濟負擔限制了許多患者獲得治療的機會，導致很大一部分人群無法負擔這些重要的治療費用。此外，與輔助生殖技術相關的倫理困境，例如對胚胎操作的擔憂以及代孕的倫理考量，也增加了市場的複雜性，並可能阻礙市場擴張。這些因素共同構成了一個限制性環境，影響著服務的可及性和整個產業的成長。

不孕症治療市場趨勢

由於消費者意識的提高和對精準醫療（尤其是體外受精（IVF）技術）的日益重視，不孕症治療市場正經歷顯著成長。基因檢測和篩檢技術的創新變得至關重要，使得胚胎選擇更加個人化成為可能，從而提高胚胎著床成功率並最大限度地降低遺傳風險。此外，面臨不孕症的個人和夫婦對第三方輔助生殖技術（例如代孕和配子捐贈）的接受度也呈現出顯著上升的趨勢。這種不斷變化的格局反映了社會整體上探索多元化生育途徑的意願，並將最終塑造不孕症治療的未來。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 監管分析
• 技術分析

全球不孕症治療市場規模（按產品和複合年成長率分類）（2026-2033 年）

• 裝置
  • 顯微鏡
  • 影像系統
  • 精子分析系統
  • 卵子吸泵
  • 微型機械手臂系統
  • 培養箱
  • 氣體分析儀
  • 雷射系統
  • 冷凍保存系統
  • 精子分離裝置
• 文化媒體與消費品
• 配件

全球不孕症治療市場規模（依治療項目及複合年成長率分類）（2026-2033 年）

• 輔助生殖技術
  • 體外受精
  • 胞漿內單一精子注射
  • 代孕
• 人工授精
  • 子宮內人工授精
  • 子宮頸內人工授精
  • 輸卵管內人工授精
• 不孕症治療手術
  • 腹腔鏡
  • 子宮鏡檢查
  • 子宮肌瘤切除術
  • 開放性手術
  • 輸卵管結紮復通手術
  • 精索靜脈曲張手術
  • 顯微重組手術
  • 輸精管再植術
  • 輸精管附睪吻合術
• 其他生育治療程序

全球不孕症治療市場規模（依病患類型分類）及複合年成長率（2026-2033 年）

• 女性不孕症治療
• 男性不孕症治療

全球不孕症治療市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

• 不孕症治療中心
• 醫院和外科診所
• 精子和卵子儲存庫
• 研究所

全球不孕症治療市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• CooperSurgical, Inc.（USA）
• Vitrolife（Sweden）
• FUJIFILM Irvine Scientific（Japan）
• Thermo Fisher Scientific, Inc.（USA）
• Cook Medical Inc.（USA）
• Hamilton Thorne Ltd.（USA）
• Esco Micro Pte. Ltd.（Singapore）
• Genea Biomedx（Australia）
• Merck KGaA（Germany）
• Ferring Pharmaceuticals（Switzerland）
• Organon & Co.（USA）
• Abbott Laboratories（USA）
• Novartis AG（Switzerland）
• Bayer AG（Germany）
• Indira IVF（India）
• Fairhaven Health（USA）
• Theralogix（USA）
• Vitabiotics Ltd.（UK）
• Exeltis（Spain）
• Zita West（UK）

結論與建議

Infertility Treatment Market size was valued at USD 4.06 Billion in 2024 and is poised to grow from USD 4.34 Billion in 2025 to USD 7.41 Billion by 2033, growing at a CAGR of 6.9% during the forecast period (2026-2033).

The global infertility treatment market is witnessing significant growth driven by several key factors, including rising infertility rates, advancing maternal age, lifestyle changes, and breakthrough medical technologies. A substantial portion of the global population experiences infertility, fueling the demand for effective and innovative treatment solutions. Assisted Reproductive Technology (ART) methods, such as in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI), have emerged as mainstream options, benefiting from continuous technological advancements that enhance success rates and patient outcomes. This market is poised for further expansion as these technologies become more accessible and affordable. Factors like the increasing acceptance of third-party reproduction, growing disposable income, and trends toward delayed parenthood also contribute to the evolving landscape of infertility treatments.

Top-down and bottom-up approaches were used to estimate and validate the size of the Infertility Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Infertility Treatment Market Segments Analysis

Global Infertility Treatment Market is segmented by Product, Procedure, Patient Type, End User and region. Based on Product, the market is segmented into Equipment, Media & Consumables and Accessories. Based on Procedure, the market is segmented into Assisted Reproductive Technology, Artificial Insemination, Fertility Surgeries and Other Infertility Treatment Procedures. Based on Patient Type, the market is segmented into Female Infertility Treatment and Male Infertility Treatment. Based on End User, the market is segmented into Fertility Centers, Hospitals & Surgical Clinics, Cryobanks and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Infertility Treatment Market

The increasing prevalence of infertility on a global scale can be attributed to factors such as lifestyle changes, postponed parenthood, and environmental influences. This rise in the number of individuals and couples facing fertility challenges has led to a growing demand for a variety of infertility treatment options. Additionally, advancements in medical technology, particularly in assisted reproductive techniques like in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI), have markedly improved success rates, thereby making these treatments more effective and accessible. Collectively, these elements are driving the growth of the infertility treatment market.

Restraints in the Infertility Treatment Market

A significant challenge facing the infertility treatment market is the high cost associated with advanced therapies like in vitro fertilization (IVF) and genetic testing. These financial burdens limit access for many individuals, making it difficult for a large segment of the population to afford these essential treatments. In addition, ethical dilemmas surrounding assisted reproductive technologies-such as concerns over embryo manipulation and the moral considerations of surrogacy-add layers of complexity that can hinder market expansion. These factors contribute to a constrained environment, affecting both the accessibility of services and overall growth within the sector.

Market Trends of the Infertility Treatment Market

The infertility treatment market is experiencing significant growth driven by rising consumer awareness and an increased emphasis on precision medicine, particularly in in vitro fertilization (IVF) techniques. Genetic testing and screening innovations are becoming essential, facilitating more personalized embryo selection that enhances the chances of successful implantation while minimizing genetic risks. Additionally, there is a notable trend towards the acceptance and utilization of third-party reproductive methods, such as surrogacy and gamete donation, which are gaining traction among individuals and couples navigating infertility challenges. This evolving landscape reflects a broader societal willingness to explore diverse pathways to parenthood, ultimately shaping the future of infertility treatment.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Regulatory Analysis
• Technology Analysis

Global Infertility Treatment Market Size by Product & CAGR (2026-2033)

• Market Overview
• Equipment
  • Microscopes
  • Imaging Systems
  • Sperm Analyzer Systems
  • Ovum Aspiration Pumps
  • Micromanipulator Systems
  • Incubators
  • Gas Analyzers
  • Laser Systems
  • Cryosystems
  • Sperm Separation Devices
• Media & Consumables
• Accessories

Global Infertility Treatment Market Size by Procedure & CAGR (2026-2033)

• Market Overview
• Assisted Reproductive Technology
  • In Vitro Fertilization
  • Intracytoplasmic Sperm Injection
  • Surrogacy
• Artificial Insemination
  • Intrauterine Insemination
  • Intracervical Insemination
  • Intratubal Insemination
• Fertility Surgeries
  • Laparoscopy
  • Hysteroscopy
  • Myomectomy
  • Laparotomy
  • Tubal Ligation Reversal
  • Varicocelectomy
  • Microsurgical Reconstruction
  • Vasovasostomy
  • Vasoepididymostomy
• Other Infertility Treatment Procedures

Global Infertility Treatment Market Size by Patient Type & CAGR (2026-2033)

• Market Overview
• Female Infertility Treatment
• Male Infertility Treatment

Global Infertility Treatment Market Size by End User & CAGR (2026-2033)

• Market Overview
• Fertility Centers
• Hospitals & Surgical Clinics
• Cryobanks
• Research Institutes

Global Infertility Treatment Market Size & CAGR (2026-2033)

• North America (Product, Procedure, Patient Type, End User)
  • US
  • Canada
• Europe (Product, Procedure, Patient Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Procedure, Patient Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Procedure, Patient Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Procedure, Patient Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• CooperSurgical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vitrolife (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM Irvine Scientific (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hamilton Thorne Ltd. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Esco Micro Pte. Ltd. (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genea Biomedx (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ferring Pharmaceuticals (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Organon & Co. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indira IVF (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fairhaven Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Theralogix (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vitabiotics Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Exeltis (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zita West (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations